method for assessing a patient, kit, computer readable medium, method for assessing a treatment, method for assessing a patient's risk, method for monitoring, method for diagnosing, testing system, method for classifying or grouping a population of individuals, method for assessing a surrogate outcome, method for treating, use of at least one biomarker, use of an agent
PROTEOMICS INTERNATIONAL PTY LTD;THE UNIVERSITY OF WESTERN AUSTRALIA
发明人:
KAYE WINFIELD,KIRSTEN PETERS,RICHARD LIPSCOMBE,SCOTT BRINGANS,TAMMY CASEY,THOMAS STOLL,TIMOTHY DAVIS,WENDY DAVIS
申请号：
BR112013006764
公开号：
BR112013006764A2
申请日:
2011.09.20
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The invention provides biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement Clq subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
